#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-7	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-2	8-13	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
1-3	14-24	functional	_
1-4	25-37	connectivity	_
1-5	38-40	of	_
1-6	41-44	the	_
1-7	45-53	amygdala	_
1-8	54-57	and	_
1-9	58-65	problem	_
1-10	66-74	drinking	_
1-11	75-77	in	_
1-12	78-91	non-dependent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
1-13	92-99	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
1-14	100-108	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
1-15	109-116	Alcohol	_
1-16	117-123	misuse	_
1-17	124-126	is	_
1-18	127-137	associated	_
1-19	138-142	with	_
1-20	143-154	dysfunction	_
1-21	155-157	of	_
1-22	158-161	the	_
1-23	162-181	amygdala-prefrontal	_
1-24	182-190	cortical	_
1-25	191-198	circuit	_
1-26	199-200	.	_

2-1	201-204	The	_
2-2	205-213	amygdala	_
2-3	214-217	and	_
2-4	218-221	its	_
2-5	222-230	cortical	_
2-6	231-238	targets	_
2-7	239-247	decrease	_
2-8	248-256	activity	_
2-9	257-263	during	_
2-10	264-265	a	_
2-11	266-273	variety	_
2-12	274-276	of	_
2-13	277-281	task	_
2-14	282-292	challenges	_
2-15	293-295	in	_
2-16	296-307	individuals	_
2-17	308-315	engaged	_
2-18	316-318	in	_
2-19	319-326	problem	_
2-20	327-335	drinking	_
2-21	336-337	.	_

3-1	338-340	On	_
3-2	341-344	the	_
3-3	345-350	other	_
3-4	351-355	hand	_
3-5	356-357	,	_
3-6	358-360	it	_
3-7	361-363	is	_
3-8	364-368	less	_
3-9	369-374	clear	_
3-10	375-378	how	_
3-11	379-387	amygdala	_
3-12	388-395	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-13	396-401	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-14	402-412	functional	_
3-15	413-425	connectivity	_
3-16	426-427	(	_
3-17	428-432	rsFC	_
3-18	433-434	)	_
3-19	435-438	may	_
3-20	439-441	be	_
3-21	442-449	altered	_
3-22	450-452	in	_
3-23	453-464	association	_
3-24	465-469	with	_
3-25	470-477	alcohol	_
3-26	478-484	misuse	_
3-27	485-488	and	_
3-28	489-496	whether	_
3-29	497-501	such	_
3-30	502-509	changes	_
3-31	510-513	are	_
3-32	514-524	restricted	_
3-33	525-527	to	_
3-34	528-538	prefrontal	_
3-35	539-547	cortical	_
3-36	548-558	structures	_
3-37	559-560	.	_

4-1	561-568	Further	_
4-2	569-570	,	_
4-3	571-574	the	_
4-4	575-585	influences	_
4-5	586-588	of	_
4-6	589-597	comorbid	_
4-7	598-607	substance	_
4-8	608-611	use	_
4-9	612-615	and	_
4-10	616-626	depression	_
4-11	627-630	and	_
4-12	631-640	potential	_
4-13	641-644	sex	_
4-14	645-656	differences	_
4-15	657-661	have	_
4-16	662-665	not	_
4-17	666-670	been	_
4-18	671-679	assessed	_
4-19	680-682	in	_
4-20	683-690	earlier	_
4-21	691-695	work	_
4-22	696-697	.	_

5-1	698-702	Here	_
5-2	703-704	,	_
5-3	705-709	with	_
5-4	710-714	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
5-5	715-719	data	_
5-6	720-724	from	_
5-7	725-726	a	_
5-8	727-733	Nathan	_
5-9	734-739	Kline	_
5-10	740-758	Institute/Rockland	_
5-11	759-765	sample	_
5-12	766-768	of	_
5-13	769-771	83	_
5-14	772-785	non-dependent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
5-15	786-793	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
5-16	794-802	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
5-17	803-804	(	_
5-18	805-807	26	_
5-19	808-811	men	_
5-20	812-813	)	_
5-21	814-815	,	_
5-22	816-818	we	_
5-23	819-828	addressed	_
5-24	829-836	changes	_
5-25	837-839	in	_
5-26	840-845	whole	_
5-27	846-851	brain	_
5-28	852-856	rsFC	_
5-29	857-859	of	_
5-30	860-863	the	_
5-31	864-872	amygdala	_
5-32	873-875	in	_
5-33	876-887	association	_
5-34	888-892	with	_
5-35	893-900	problem	_
5-36	901-909	drinking	_
5-37	910-912	as	_
5-38	913-920	indexed	_
5-39	921-923	by	_
5-40	924-926	an	_
5-41	927-934	alcohol	_
5-42	935-946	involvement	_
5-43	947-952	score	_
5-44	953-954	.	_

6-1	955-962	Imaging	_
6-2	963-967	data	_
6-3	968-972	were	_
6-4	973-982	processed	_
6-5	983-987	with	_
6-6	988-999	Statistical	_
6-7	1000-1010	Parametric	_
6-8	1011-1018	Mapping	_
6-9	1019-1028	following	_
6-10	1029-1037	standard	_
6-11	1038-1046	routines	_
6-12	1047-1050	and	_
6-13	1051-1054	all	_
6-14	1055-1062	results	_
6-15	1063-1067	were	_
6-16	1068-1076	examined	_
6-17	1077-1079	at	_
6-18	1080-1085	voxel	_
6-19	1086-1087	p	_
6-20	1088-1089	<	_
6-21	1090-1095	0.001	_
6-22	1096-1107	uncorrected	_
6-23	1108-1110	in	_
6-24	1111-1122	combination	_
6-25	1123-1127	with	_
6-26	1128-1135	cluster	_
6-27	1136-1137	p	_
6-28	1138-1139	<	_
6-29	1140-1144	0.05	_
6-30	1145-1154	corrected	_
6-31	1155-1158	for	_
6-32	1159-1164	false	_
6-33	1165-1174	discovery	_
6-34	1175-1179	rate	_
6-35	1180-1181	.	_

7-1	1182-1189	Alcohol	_
7-2	1190-1196	misuse	_
7-3	1197-1200	was	_
7-4	1201-1211	correlated	_
7-5	1212-1216	with	_
7-6	1217-1226	decreased	_
7-7	1227-1235	amygdala	_
7-8	1236-1248	connectivity	_
7-9	1249-1253	with	_
7-10	1254-1257	the	_
7-11	1258-1264	dorsal	_
7-12	1265-1273	anterior	_
7-13	1274-1283	cingulate	_
7-14	1284-1290	cortex	_
7-15	1291-1292	(	_
7-16	1293-1297	dACC	_
7-17	1298-1299	)	_
7-18	1300-1312	irrespective	_
7-19	1313-1315	of	_
7-20	1316-1326	depression	_
7-21	1327-1330	and	_
7-22	1331-1336	other	_
7-23	1337-1346	substance	_
7-24	1347-1350	use	_
7-25	1351-1352	.	_

8-1	1353-1360	Changes	_
8-2	1361-1363	in	_
8-3	1364-1377	amygdala-dACC	_
8-4	1378-1390	connectivity	_
8-5	1391-1401	manifested	_
8-6	1402-1404	in	_
8-7	1405-1408	the	_
8-8	1409-1421	latero-basal	_
8-9	1422-1433	subdivision	_
8-10	1434-1436	of	_
8-11	1437-1440	the	_
8-12	1441-1449	amygdala	_
8-13	1450-1451	.	_

9-1	1452-1459	Further	_
9-2	1460-1461	,	_
9-3	1462-1465	men	_
9-4	1466-1468	as	_
9-5	1469-1477	compared	_
9-6	1478-1480	to	_
9-7	1481-1486	women	_
9-8	1487-1493	showed	_
9-9	1494-1495	a	_
9-10	1496-1509	significantly	_
9-11	1510-1518	stronger	_
9-12	1519-1531	relationship	_
9-13	1532-1534	in	_
9-14	1535-1544	decreased	_
9-15	1545-1558	amygdala-dACC	_
9-16	1559-1571	connectivity	_
9-17	1572-1575	and	_
9-18	1576-1583	problem	_
9-19	1584-1592	drinking	_
9-20	1593-1594	,	_
9-21	1595-1603	although	_
9-22	1604-1606	it	_
9-23	1607-1613	should	_
9-24	1614-1616	be	_
9-25	1617-1622	noted	_
9-26	1623-1627	that	_
9-27	1628-1631	men	_
9-28	1632-1636	also	_
9-29	1637-1643	showed	_
9-30	1644-1645	a	_
9-31	1646-1651	trend	_
9-32	1652-1658	toward	_
9-33	1659-1665	higher	_
9-34	1666-1673	alcohol	_
9-35	1674-1685	involvement	_
9-36	1686-1691	score	_
9-37	1692-1696	than	_
9-38	1697-1702	women	_
9-39	1703-1704	.	_

10-1	1705-1708	The	_
10-2	1709-1717	findings	_
10-3	1718-1721	add	_
10-4	1722-1724	to	_
10-5	1725-1726	a	_
10-6	1727-1734	growing	_
10-7	1735-1745	literature	_
10-8	1746-1757	documenting	_
10-9	1758-1767	disrupted	_
10-10	1768-1787	amygdala-prefrontal	_
10-11	1788-1796	cortical	_
10-12	1797-1806	functions	_
10-13	1807-1809	in	_
10-14	1810-1818	relation	_
10-15	1819-1821	to	_
10-16	1822-1829	alcohol	_
10-17	1830-1836	misuse	_
10-18	1837-1838	.	_

11-1	1839-1840	2	_
11-2	1841-1842	.	_

12-1	1843-1850	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
12-2	1851-1854	2.1	_
12-3	1855-1859	Data	_
12-4	1860-1863	set	_
12-5	1864-1877	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
12-6	1878-1882	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
12-7	1883-1887	data	_
12-8	1888-1892	were	_
12-9	1893-1901	obtained	_
12-10	1902-1906	from	_
12-11	1907-1910	the	_
12-12	1911-1917	Nathan	_
12-13	1918-1923	Kline	_
12-14	1924-1933	Institute	_
12-15	1934-1935	(	_
12-16	1936-1939	NKI	_
12-17	1940-1941	)	_
12-18	1942-1951	/Rockland	_
12-19	1952-1958	sample	_
12-20	1959-1961	of	_
12-21	1962-1965	the	_
12-22	1966-1971	1,000	_
12-23	1972-1982	Functional	_
12-24	1983-1994	Connectomes	_
12-25	1995-2002	project	_
12-26	2003-2004	(	_
12-27	2005-2009	http	_
12-28	2010-2011	:	_
12-29	2012-2047	//www.nitrc.org/projects/fcon_1000/	_
12-30	2048-2049	)	_
12-31	2050-2051	.	_

13-1	2052-2056	This	_
13-2	2057-2064	dataset	_
13-3	2065-2068	has	_
13-4	2069-2073	been	_
13-5	2074-2078	used	_
13-6	2079-2081	in	_
13-7	2082-2090	previous	_
13-8	2091-2099	research	_
13-9	2100-2102	of	_
13-10	2103-2108	brain	_
13-11	2109-2118	circuitry	_
13-12	2119-2121	in	_
13-13	2122-2129	healthy	_
13-14	2130-2136	adults	_
13-15	2137-2140	and	_
13-16	2141-2149	patients	_
13-17	2150-2154	with	_
13-18	2155-2162	medical	_
13-19	2163-2166	and	_
13-20	2167-2178	psychiatric	_
13-21	2179-2189	conditions	_
13-22	2190-2191	.	_

14-1	2192-2197	Scans	_
14-2	2198-2202	were	_
14-3	2203-2212	collected	_
14-4	2213-2218	using	_
14-5	2219-2220	a	_
14-6	2221-2230	multiband	_
14-7	2231-2234	EPI	_
14-8	2235-2243	sequence	_
14-9	2244-2248	with	_
14-10	2249-2252	the	_
14-11	2253-2262	following	_
14-12	2263-2273	parameters	_
14-13	2274-2275	:	_
14-14	2276-2286	repetition	_
14-15	2287-2291	time	_
14-16	2292-2293	(	_
14-17	2294-2296	TR	_
14-18	2297-2298	)	_
14-19	2299-2304	/echo	_
14-20	2305-2309	time	_
14-21	2310-2311	(	_
14-22	2312-2314	TE	_
14-23	2315-2316	)	_
14-24	2317-2318	=	_
14-25	2319-2326	2500/30	_
14-26	2327-2329	ms	_
14-27	2330-2331	,	_
14-28	2332-2337	voxel	_
14-29	2338-2342	size	_
14-30	2343-2344	=	_
14-31	2345-2348	3.0	_
14-32	2349-2350	×	_
14-33	2351-2354	3.0	_
14-34	2355-2356	×	_
14-35	2357-2360	3.0	_
14-36	2361-2364	mm3	_
14-37	2365-2366	,	_
14-38	2367-2370	and	_
14-39	2371-2373	38	_
14-40	2374-2380	slices	_
14-41	2381-2382	,	_
14-42	2383-2391	covering	_
14-43	2392-2395	the	_
14-44	2396-2401	whole	_
14-45	2402-2407	brain	_
14-46	2408-2409	.	_

15-1	2410-2420	Individual	_
15-2	2421-2422	’	_
15-3	2423-2424	s	_
15-4	2425-2431	images	_
15-5	2432-2436	were	_
15-6	2437-2443	viewed	_
15-7	2444-2447	one	_
15-8	2448-2450	by	_
15-9	2451-2454	one	_
15-10	2455-2457	to	_
15-11	2458-2464	ensure	_
15-12	2465-2469	that	_
15-13	2470-2473	the	_
15-14	2474-2479	whole	_
15-15	2480-2485	brain	_
15-16	2486-2489	was	_
15-17	2490-2497	covered	_
15-18	2498-2499	.	_

16-1	2500-2512	Participants	_
16-2	2513-2517	were	_
16-3	2518-2526	assessed	_
16-4	2527-2530	for	_
16-5	2531-2539	drinking	_
16-6	2540-2548	behavior	_
16-7	2549-2553	with	_
16-8	2554-2557	the	_
16-9	2558-2562	NIDA	_
16-10	2563-2568	Quick	_
16-11	2569-2575	Screen	_
16-12	2576-2581	V1.01	_
16-13	2582-2583	(	_
16-14	2584-2587	11+	_
16-15	2588-2589	)	_
16-16	2590-2591	.	_

17-1	2592-2593	A	_
17-2	2594-2599	total	_
17-3	2600-2602	of	_
17-4	2603-2605	83	_
17-5	2606-2611	adult	_
17-6	2612-2624	participants	_
17-7	2625-2626	(	_
17-8	2627-2632	18–89	_
17-9	2633-2638	years	_
17-10	2639-2641	of	_
17-11	2642-2645	age	_
17-12	2646-2647	;	_
17-13	2648-2650	26	_
17-14	2651-2656	males	_
17-15	2657-2658	;	_
17-16	2659-2662	one	_
17-17	2663-2674	five-minute	_
17-18	2675-2679	scan	_
17-19	2680-2683	per	_
17-20	2684-2695	participant	_
17-21	2696-2701	under	_
17-22	2702-2711	identical	_
17-23	2712-2719	imaging	_
17-24	2720-2728	protocol	_
17-25	2729-2730	)	_
17-26	2731-2735	with	_
17-27	2736-2737	a	_
17-28	2738-2747	substance	_
17-29	2748-2759	involvement	_
17-30	2760-2761	(	_
17-31	2762-2764	SI	_
17-32	2765-2766	)	_
17-33	2767-2772	score	_
17-34	2773-2775	of	_
17-35	2776-2783	alcohol	_
17-36	2784-2787	use	_
17-37	2788-2792	were	_
17-38	2793-2801	included	_
17-39	2802-2804	in	_
17-40	2805-2808	the	_
17-41	2809-2816	current	_
17-42	2817-2823	cohort	_
17-43	2824-2825	.	_

18-1	2826-2833	Briefly	_
18-2	2834-2835	,	_
18-3	2836-2839	the	_
18-4	2840-2849	screening	_
18-5	2850-2855	asked	_
18-6	2856-2861	about	_
18-7	2862-2874	participants	_
18-8	2875-2876	’	_
18-9	2877-2885	drinking	_
18-10	2886-2894	behavior	_
18-11	2895-2904	including	_
18-12	2905-2908	the	_
18-13	2909-2918	frequency	_
18-14	2919-2920	,	_
18-15	2921-2927	desire	_
18-16	2928-2929	,	_
18-17	2930-2936	amount	_
18-18	2937-2939	of	_
18-19	2940-2947	alcohol	_
18-20	2948-2949	,	_
18-21	2950-2952	as	_
18-22	2953-2957	well	_
18-23	2958-2960	as	_
18-24	2961-2967	social	_
18-25	2968-2979	disruptions	_
18-26	2980-2984	that	_
18-27	2985-2993	resulted	_
18-28	2994-2998	from	_
18-29	2999-3006	alcohol	_
18-30	3007-3015	drinking	_
18-31	3016-3017	,	_
18-32	3018-3027	including	_
18-33	3028-3035	whether	_
18-34	3036-3040	they	_
18-35	3041-3046	drink	_
18-36	3047-3049	or	_
18-37	3050-3053	not	_
18-38	3054-3060	during	_
18-39	3061-3066	their	_
18-40	3067-3075	lifetime	_
18-41	3076-3077	(	_
18-42	3078-3084	yes/no	_
18-43	3085-3086	)	_
18-44	3087-3088	,	_
18-45	3089-3092	and	_
18-46	3093-3101	drinking	_
18-47	3102-3110	behavior	_
18-48	3111-3113	in	_
18-49	3114-3117	the	_
18-50	3118-3122	past	_
18-51	3123-3127	year	_
18-52	3128-3131	and	_
18-53	3132-3136	past	_
18-54	3137-3138	3	_
18-55	3139-3145	months	_
18-56	3146-3147	.	_

19-1	3148-3151	The	_
19-2	3152-3157	total	_
19-3	3158-3160	SI	_
19-4	3161-3166	score	_
19-5	3167-3169	of	_
19-6	3170-3177	alcohol	_
19-7	3178-3181	was	_
19-8	3182-3188	summed	_
19-9	3189-3193	from	_
19-10	3194-3200	scores	_
19-11	3201-3203	of	_
19-12	3204-3208	each	_
19-13	3209-3216	alcohol	_
19-14	3217-3224	related	_
19-15	3225-3233	question	_
19-16	3234-3238	with	_
19-17	3239-3240	a	_
19-18	3241-3247	higher	_
19-19	3248-3250	SI	_
19-20	3251-3256	score	_
19-21	3257-3267	indicating	_
19-22	3268-3274	higher	_
19-23	3275-3286	involvement	_
19-24	3287-3289	in	_
19-25	3290-3297	alcohol	_
19-26	3298-3304	misuse	_
19-27	3305-3306	(	_
19-28	3307-3315	Appendix	_
19-29	3316-3317	I	_
19-30	3318-3319	)	_
19-31	3320-3321	.	_

20-1	3322-3324	Of	_
20-2	3325-3328	the	_
20-3	3329-3331	83	_
20-4	3332-3344	participants	_
20-5	3345-3346	,	_
20-6	3347-3349	14	_
20-7	3350-3354	were	_
20-8	3355-3364	diagnosed	_
20-9	3365-3369	with	_
20-10	3370-3374	drug	_
20-11	3375-3385	dependence	_
20-12	3386-3388	or	_
20-13	3389-3394	abuse	_
20-14	3395-3396	(	_
20-15	3397-3398	1	_
20-16	3399-3406	cocaine	_
20-17	3407-3417	dependence	_
20-18	3418-3419	,	_
20-19	3420-3421	3	_
20-20	3422-3430	cannabis	_
20-21	3431-3441	dependence	_
20-22	3442-3443	,	_
20-23	3444-3447	and	_
20-24	3448-3450	10	_
20-25	3451-3459	cannabis	_
20-26	3460-3465	abuse	_
20-27	3466-3467	)	_
20-28	3468-3469	,	_
20-29	3470-3473	and	_
20-30	3474-3476	10	_
20-31	3477-3481	with	_
20-32	3482-3483	a	_
20-33	3484-3494	depressive	_
20-34	3495-3503	disorder	_
20-35	3504-3505	,	_
20-36	3506-3515	according	_
20-37	3516-3518	to	_
20-38	3519-3522	the	_
20-39	3523-3528	ICD-9	_
20-40	3529-3530	.	_

21-1	3531-3534	2.2	_
21-2	3535-3542	Imaging	_
21-3	3543-3547	data	_
21-4	3548-3561	preprocessing	_
21-5	3562-3567	Brain	_
21-6	3568-3575	imaging	_
21-7	3576-3580	data	_
21-8	3581-3585	were	_
21-9	3586-3598	preprocessed	_
21-10	3599-3604	using	_
21-11	3605-3616	Statistical	_
21-12	3617-3627	Parametric	_
21-13	3628-3635	Mapping	_
21-14	3636-3637	(	_
21-15	3638-3641	SPM	_
21-16	3642-3643	8	_
21-17	3644-3645	,	_
21-18	3646-3654	Wellcome	_
21-19	3655-3665	Department	_
21-20	3666-3668	of	_
21-21	3669-3676	Imaging	_
21-22	3677-3689	Neuroscience	_
21-23	3690-3691	,	_
21-24	3692-3702	University	_
21-25	3703-3710	College	_
21-26	3711-3717	London	_
21-27	3718-3719	,	_
21-28	3720-3724	U.K.	_
21-29	3725-3726	)	_
21-30	3727-3728	.	_

22-1	3729-3737	Standard	_
22-2	3738-3743	image	_
22-3	3744-3757	preprocessing	_
22-4	3758-3761	was	_
22-5	3762-3771	performed	_
22-6	3772-3773	.	_

23-1	3774-3780	Images	_
23-2	3781-3783	of	_
23-3	3784-3788	each	_
23-4	3789-3799	individual	_
23-5	3800-3807	subject	_
23-6	3808-3812	were	_
23-7	3813-3818	first	_
23-8	3819-3828	realigned	_
23-9	3829-3830	(	_
23-10	3831-3837	motion	_
23-11	3838-3847	corrected	_
23-12	3848-3849	)	_
23-13	3850-3853	and	_
23-14	3854-3863	corrected	_
23-15	3864-3867	for	_
23-16	3868-3873	slice	_
23-17	3874-3880	timing	_
23-18	3881-3882	.	_

24-1	3883-3884	A	_
24-2	3885-3889	mean	_
24-3	3890-3900	functional	_
24-4	3901-3906	image	_
24-5	3907-3913	volume	_
24-6	3914-3917	was	_
24-7	3918-3929	constructed	_
24-8	3930-3933	for	_
24-9	3934-3938	each	_
24-10	3939-3946	subject	_
24-11	3947-3950	per	_
24-12	3951-3954	run	_
24-13	3955-3959	from	_
24-14	3960-3963	the	_
24-15	3964-3973	realigned	_
24-16	3974-3979	image	_
24-17	3980-3987	volumes	_
24-18	3988-3989	.	_

25-1	3990-3995	These	_
25-2	3996-4000	mean	_
25-3	4001-4007	images	_
25-4	4008-4012	were	_
25-5	4013-4026	co-registered	_
25-6	4027-4031	with	_
25-7	4032-4035	the	_
25-8	4036-4040	high	_
25-9	4041-4051	resolution	_
25-10	4052-4062	structural	_
25-11	4063-4068	image	_
25-12	4069-4072	and	_
25-13	4073-4077	then	_
25-14	4078-4087	segmented	_
25-15	4088-4091	for	_
25-16	4092-4105	normalization	_
25-17	4106-4110	with	_
25-18	4111-4117	affine	_
25-19	4118-4130	registration	_
25-20	4131-4139	followed	_
25-21	4140-4142	by	_
25-22	4143-4152	nonlinear	_
25-23	4153-4167	transformation	_
25-24	4168-4169	.	_

26-1	4170-4173	The	_
26-2	4174-4187	normalization	_
26-3	4188-4198	parameters	_
26-4	4199-4209	determined	_
26-5	4210-4213	for	_
26-6	4214-4217	the	_
26-7	4218-4227	structure	_
26-8	4228-4234	volume	_
26-9	4235-4239	were	_
26-10	4240-4244	then	_
26-11	4245-4252	applied	_
26-12	4253-4255	to	_
26-13	4256-4259	the	_
26-14	4260-4273	corresponding	_
26-15	4274-4284	functional	_
26-16	4285-4290	image	_
26-17	4291-4298	volumes	_
26-18	4299-4302	for	_
26-19	4303-4307	each	_
26-20	4308-4315	subject	_
26-21	4316-4317	.	_

27-1	4318-4325	Finally	_
27-2	4326-4327	,	_
27-3	4328-4331	the	_
27-4	4332-4338	images	_
27-5	4339-4343	were	_
27-6	4344-4352	smoothed	_
27-7	4353-4357	with	_
27-8	4358-4359	a	_
27-9	4360-4368	Gaussian	_
27-10	4369-4375	kernel	_
27-11	4376-4378	of	_
27-12	4379-4380	8	_
27-13	4381-4383	mm	_
27-14	4384-4386	at	_
27-15	4387-4391	Full	_
27-16	4392-4397	Width	_
27-17	4398-4400	at	_
27-18	4401-4405	Half	_
27-19	4406-4413	Maximum	_
27-20	4414-4415	.	_

28-1	4416-4426	Additional	_
28-2	4427-4440	preprocessing	_
28-3	4441-4444	was	_
28-4	4445-4452	applied	_
28-5	4453-4455	to	_
28-6	4456-4462	reduce	_
28-7	4463-4471	spurious	_
28-8	4472-4495	blood-oxygenation-level	_
28-9	4496-4505	dependent	_
28-10	4506-4507	(	_
28-11	4508-4512	BOLD	_
28-12	4513-4514	)	_
28-13	4515-4524	variances	_
28-14	4525-4529	that	_
28-15	4530-4534	were	_
28-16	4535-4543	unlikely	_
28-17	4544-4546	to	_
28-18	4547-4554	reflect	_
28-19	4555-4563	neuronal	_
28-20	4564-4572	activity	_
28-21	4573-4574	.	_

29-1	4575-4578	The	_
29-2	4579-4586	sources	_
29-3	4587-4589	of	_
29-4	4590-4598	spurious	_
29-5	4599-4607	variance	_
29-6	4608-4612	were	_
29-7	4613-4620	removed	_
29-8	4621-4628	through	_
29-9	4629-4635	linear	_
29-10	4636-4646	regression	_
29-11	4647-4649	by	_
29-12	4650-4659	including	_
29-13	4660-4663	the	_
29-14	4664-4670	signal	_
29-15	4671-4675	from	_
29-16	4676-4679	the	_
29-17	4680-4691	ventricular	_
29-18	4692-4698	system	_
29-19	4699-4700	,	_
29-20	4701-4706	white	_
29-21	4707-4713	matter	_
29-22	4714-4715	,	_
29-23	4716-4719	and	_
29-24	4720-4725	whole	_
29-25	4726-4731	brain	_
29-26	4732-4733	,	_
29-27	4734-4736	in	_
29-28	4737-4745	addition	_
29-29	4746-4748	to	_
29-30	4749-4752	the	_
29-31	4753-4756	six	_
29-32	4757-4767	parameters	_
29-33	4768-4776	obtained	_
29-34	4777-4779	by	_
29-35	4780-4785	rigid	_
29-36	4786-4790	body	_
29-37	4791-4795	head	_
29-38	4796-4802	motion	_
29-39	4803-4813	correction	_
29-40	4814-4815	.	_

30-1	4816-4827	First-order	_
30-2	4828-4839	derivatives	_
30-3	4840-4842	of	_
30-4	4843-4846	the	_
30-5	4847-4852	whole	_
30-6	4853-4858	brain	_
30-7	4859-4860	,	_
30-8	4861-4872	ventricular	_
30-9	4873-4876	and	_
30-10	4877-4882	white	_
30-11	4883-4889	matter	_
30-12	4890-4897	signals	_
30-13	4898-4902	were	_
30-14	4903-4907	also	_
30-15	4908-4916	included	_
30-16	4917-4919	in	_
30-17	4920-4923	the	_
30-18	4924-4934	regression	_
30-19	4935-4936	.	_

31-1	4937-4945	Previous	_
31-2	4946-4953	studies	_
31-3	4954-4963	suggested	_
31-4	4964-4968	that	_
31-5	4969-4973	BOLD	_
31-6	4974-4986	fluctuations	_
31-7	4987-4992	below	_
31-8	4993-4994	a	_
31-9	4995-5004	frequency	_
31-10	5005-5007	of	_
31-11	5008-5013	0.1Hz	_
31-12	5014-5024	contribute	_
31-13	5025-5027	to	_
31-14	5028-5038	regionally	_
31-15	5039-5047	specific	_
31-16	5048-5052	BOLD	_
31-17	5053-5065	correlations	_
31-18	5066-5067	.	_

32-1	5068-5072	Thus	_
32-2	5073-5074	,	_
32-3	5075-5077	we	_
32-4	5078-5085	applied	_
32-5	5086-5087	a	_
32-6	5088-5096	temporal	_
32-7	5097-5106	band-pass	_
32-8	5107-5113	filter	_
32-9	5114-5115	(	_
32-10	5116-5121	0.009	_
32-11	5122-5123	<	_
32-12	5124-5125	f	_
32-13	5126-5127	<	_
32-14	5128-5132	0.08	_
32-15	5133-5135	Hz	_
32-16	5136-5137	)	_
32-17	5138-5140	to	_
32-18	5141-5144	the	_
32-19	5145-5149	time	_
32-20	5150-5156	course	_
32-21	5157-5159	in	_
32-22	5160-5165	order	_
32-23	5166-5168	to	_
32-24	5169-5175	obtain	_
32-25	5176-5189	low-frequency	_
32-26	5190-5202	fluctuations	_
32-27	5203-5204	,	_
32-28	5205-5207	as	_
32-29	5208-5210	in	_
32-30	5211-5219	previous	_
32-31	5220-5227	studies	_
32-32	5228-5229	.	_

33-1	5230-5233	2.3	_
33-2	5234-5238	Head	_
33-3	5239-5245	motion	_
33-4	5246-5248	As	_
33-5	5249-5260	extensively	_
33-6	5261-5273	investigated	_
33-7	5274-5276	by	_
33-8	5277-5278	,	_
33-9	5279-5284	micro	_
33-10	5285-5289	head	_
33-11	5290-5296	motion	_
33-12	5297-5298	(	_
33-13	5299-5300	>	_
33-14	5301-5306	0.1mm	_
33-15	5307-5308	)	_
33-16	5309-5311	is	_
33-17	5312-5314	an	_
33-18	5315-5324	important	_
33-19	5325-5331	source	_
33-20	5332-5334	of	_
33-21	5335-5343	spurious	_
33-22	5344-5356	correlations	_
33-23	5357-5359	in	_
33-24	5360-5367	resting	_
33-25	5368-5373	state	_
33-26	5374-5384	functional	_
33-27	5385-5397	connectivity	_
33-28	5398-5406	analysis	_
33-29	5407-5408	.	_

34-1	5409-5418	Therefore	_
34-2	5419-5420	,	_
34-3	5421-5423	we	_
34-4	5424-5431	applied	_
34-5	5432-5433	a	_
34-6	5434-5435	“	_
34-7	5436-5445	scrubbing	_
34-8	5446-5447	”	_
34-9	5448-5454	method	_
34-10	5455-5463	proposed	_
34-11	5464-5466	by	_
34-12	5467-5472	Power	_
34-13	5473-5476	and	_
34-14	5477-5487	colleagues	_
34-15	5488-5491	and	_
34-16	5492-5504	successfully	_
34-17	5505-5512	applied	_
34-18	5513-5515	in	_
34-19	5516-5524	previous	_
34-20	5525-5532	studies	_
34-21	5533-5535	to	_
34-22	5536-5542	remove	_
34-23	5543-5547	time	_
34-24	5548-5554	points	_
34-25	5555-5563	affected	_
34-26	5564-5566	by	_
34-27	5567-5571	head	_
34-28	5572-5579	motions	_
34-29	5580-5581	.	_

35-1	5582-5589	Briefly	_
35-2	5590-5591	,	_
35-3	5592-5595	for	_
35-4	5596-5601	every	_
35-5	5602-5606	time	_
35-6	5607-5612	point	_
35-7	5613-5614	t	_
35-8	5615-5616	,	_
35-9	5617-5619	we	_
35-10	5620-5628	computed	_
35-11	5629-5632	the	_
35-12	5633-5642	framewise	_
35-13	5643-5655	displacement	_
35-14	5656-5661	given	_
35-15	5662-5664	by	_
35-16	5665-5667	FD	_
35-17	5668-5669	(	_
35-18	5670-5671	t	_
35-19	5672-5673	)	_
35-20	5674-5675	=	_
35-21	5676-5680	|Δdx	_
35-22	5681-5682	(	_
35-23	5683-5684	t	_
35-24	5685-5686	)	_
35-25	5687-5688	|	_
35-26	5689-5690	+	_
35-27	5691-5695	|Δdy	_
35-28	5696-5697	(	_
35-29	5698-5699	t	_
35-30	5700-5701	)	_
35-31	5702-5703	|	_
35-32	5704-5705	+	_
35-33	5706-5710	|Δdz	_
35-34	5711-5712	(	_
35-35	5713-5714	t	_
35-36	5715-5716	)	_
35-37	5717-5718	|	_
35-38	5719-5720	+	_
35-39	5721-5724	r|α	_
35-40	5725-5726	(	_
35-41	5727-5728	t	_
35-42	5729-5730	)	_
35-43	5731-5732	|	_
35-44	5733-5734	+	_
35-45	5735-5738	r|β	_
35-46	5739-5740	(	_
35-47	5741-5742	t	_
35-48	5743-5744	)	_
35-49	5745-5746	|	_
35-50	5747-5748	+	_
35-51	5749-5752	r|γ	_
35-52	5753-5754	(	_
35-53	5755-5756	t	_
35-54	5757-5758	)	_
35-55	5759-5760	|	_
35-56	5761-5762	,	_
35-57	5763-5768	where	_
35-58	5769-5770	(	_
35-59	5771-5773	dx	_
35-60	5774-5775	,	_
35-61	5776-5778	dy	_
35-62	5779-5780	,	_
35-63	5781-5783	dz	_
35-64	5784-5785	)	_
35-65	5786-5789	and	_
35-66	5790-5791	(	_
35-67	5792-5793	α	_
35-68	5794-5795	,	_
35-69	5796-5797	β	_
35-70	5798-5799	,	_
35-71	5800-5801	γ	_
35-72	5802-5803	)	_
35-73	5804-5807	are	_
35-74	5808-5811	the	_
35-75	5812-5825	translational	_
35-76	5826-5829	and	_
35-77	5830-5840	rotational	_
35-78	5841-5850	movements	_
35-79	5851-5852	,	_
35-80	5853-5865	respectively	_
35-81	5866-5867	,	_
35-82	5868-5871	and	_
35-83	5872-5873	r	_
35-84	5874-5875	(	_
35-85	5876-5877	=	_
35-86	5878-5882	50mm	_
35-87	5883-5884	)	_
35-88	5885-5887	is	_
35-89	5888-5889	a	_
35-90	5890-5898	constant	_
35-91	5899-5903	that	_
35-92	5904-5916	approximates	_
35-93	5917-5920	the	_
35-94	5921-5925	mean	_
35-95	5926-5934	distance	_
35-96	5935-5942	between	_
35-97	5943-5949	center	_
35-98	5950-5952	of	_
35-99	5953-5956	MNI	_
35-100	5957-5962	space	_
35-101	5963-5966	and	_
35-102	5967-5970	the	_
35-103	5971-5977	cortex	_
35-104	5978-5981	and	_
35-105	5982-5991	transform	_
35-106	5992-6001	rotations	_
35-107	6002-6006	into	_
35-108	6007-6020	displacements	_
35-109	6021-6022	.	_

36-1	6023-6026	The	_
36-2	6027-6033	second	_
36-3	6034-6038	head	_
36-4	6039-6047	movement	_
36-5	6048-6054	metric	_
36-6	6055-6058	was	_
36-7	6059-6062	the	_
36-8	6063-6067	root	_
36-9	6068-6072	mean	_
36-10	6073-6079	square	_
36-11	6080-6088	variance	_
36-12	6089-6090	(	_
36-13	6091-6096	DVARS	_
36-14	6097-6098	)	_
36-15	6099-6101	of	_
36-16	6102-6105	the	_
36-17	6106-6117	differences	_
36-18	6118-6120	in	_
36-19	6121-6122	%	_
36-20	6123-6127	BOLD	_
36-21	6128-6137	intensity	_
36-22	6138-6139	I	_
36-23	6140-6141	(	_
36-24	6142-6143	t	_
36-25	6144-6145	)	_
36-26	6146-6153	between	_
36-27	6154-6165	consecutive	_
36-28	6166-6170	time	_
36-29	6171-6177	points	_
36-30	6178-6184	across	_
36-31	6185-6190	brain	_
36-32	6191-6197	voxels	_
36-33	6198-6199	,	_
36-34	6200-6208	computed	_
36-35	6209-6211	as	_
36-36	6212-6219	follows	_
36-37	6220-6221	:	_
36-38	6222-6223	,	_
36-39	6224-6229	where	_
36-40	6230-6233	the	_
36-41	6234-6242	brackets	_
36-42	6243-6251	indicate	_
36-43	6252-6255	the	_
36-44	6256-6260	mean	_
36-45	6261-6267	across	_
36-46	6268-6273	brain	_
36-47	6274-6280	voxels	_
36-48	6281-6282	.	_

37-1	6283-6290	Finally	_
37-2	6291-6292	,	_
37-3	6293-6295	to	_
37-4	6296-6303	compute	_
37-5	6304-6308	each	_
37-6	6309-6316	subject	_
37-7	6317-6318	’	_
37-8	6319-6320	s	_
37-9	6321-6332	correlation	_
37-10	6333-6336	map	_
37-11	6337-6338	,	_
37-12	6339-6341	we	_
37-13	6342-6349	removed	_
37-14	6350-6355	every	_
37-15	6356-6360	time	_
37-16	6361-6366	point	_
37-17	6367-6371	that	_
37-18	6372-6380	exceeded	_
37-19	6381-6384	the	_
37-20	6385-6389	head	_
37-21	6390-6396	motion	_
37-22	6397-6402	limit	_
37-23	6403-6405	FD	_
37-24	6406-6407	(	_
37-25	6408-6409	t	_
37-26	6410-6411	)	_
37-27	6412-6413	>	_
37-28	6414-6419	0.5mm	_
37-29	6420-6422	or	_
37-30	6423-6428	DVARS	_
37-31	6429-6430	(	_
37-32	6431-6432	t	_
37-33	6433-6434	)	_
37-34	6435-6436	>	_
37-35	6437-6440	0.5	_
37-36	6441-6442	%	_
37-37	6443-6444	.	_

38-1	6445-6447	On	_
38-2	6448-6455	average	_
38-3	6456-6457	,	_
38-4	6458-6459	1	_
38-5	6460-6461	%	_
38-6	6462-6464	of	_
38-7	6465-6468	the	_
38-8	6469-6473	time	_
38-9	6474-6480	points	_
38-10	6481-6485	were	_
38-11	6486-6493	removed	_
38-12	6494-6500	across	_
38-13	6501-6513	participants	_
38-14	6514-6515	.	_

39-1	6516-6518	We	_
39-2	6519-6527	excluded	_
39-3	6528-6539	individuals	_
39-4	6540-6543	who	_
39-5	6544-6549	moved	_
39-6	6550-6551	>	_
39-7	6552-6553	1	_
39-8	6554-6559	voxel	_
39-9	6560-6562	in	_
39-10	6563-6566	any	_
39-11	6567-6577	directions	_
39-12	6578-6581	and	_
39-13	6582-6587	those	_
39-14	6588-6592	with	_
39-15	6593-6600	greater	_
39-16	6601-6605	than	_
39-17	6606-6611	10–20	_
39-18	6612-6613	%	_
39-19	6614-6616	of	_
39-20	6617-6624	volumes	_
39-21	6625-6633	affected	_
39-22	6634-6636	by	_
39-23	6637-6651	micromovements	_
39-24	6652-6653	.	_

40-1	6654-6657	2.4	_
40-2	6658-6662	Seed	_
40-3	6663-6670	regions	_
40-4	6671-6672	:	_
40-5	6673-6681	amygdala	_
40-6	6682-6685	The	_
40-7	6686-6690	mask	_
40-8	6691-6693	of	_
40-9	6694-6702	amygdala	_
40-10	6703-6706	was	_
40-11	6707-6715	obtained	_
40-12	6716-6720	from	_
40-13	6721-6724	the	_
40-14	6725-6728	SPM	_
40-15	6729-6736	Anatomy	_
40-16	6737-6744	Toolbox	_
40-17	6745-6752	Version	_
40-18	6753-6757	2.2c	_
40-19	6758-6759	.	_

41-1	6760-6762	It	_
41-2	6763-6766	was	_
41-3	6767-6774	created	_
41-4	6775-6780	based	_
41-5	6781-6783	on	_
41-6	6784-6787	the	_
41-7	6788-6805	cytoarchitectonic	_
41-8	6806-6819	probabilistic	_
41-9	6820-6823	map	_
41-10	6824-6829	where	_
41-11	6830-6834	four	_
41-12	6835-6847	subdivisions	_
41-13	6848-6852	were	_
41-14	6853-6863	segregated	_
41-15	6864-6865	,	_
41-16	6866-6875	including	_
41-17	6876-6879	the	_
41-18	6880-6891	superficial	_
41-19	6892-6893	,	_
41-20	6894-6906	latero-basal	_
41-21	6907-6908	,	_
41-22	6909-6922	centro-medial	_
41-23	6923-6924	,	_
41-24	6925-6928	and	_
41-25	6929-6945	amygdalostriatal	_
41-26	6946-6956	transition	_
41-27	6957-6961	area	_
41-28	6962-6963	(	_
41-29	6964-6970	Figure	_
41-30	6971-6972	1	_
41-31	6973-6974	)	_
41-32	6975-6976	.	_

42-1	6977-6979	In	_
42-2	6980-6984	rsFC	_
42-3	6985-6993	analyses	_
42-4	6994-6995	,	_
42-5	6996-6998	we	_
42-6	6999-7006	focused	_
42-7	7007-7009	on	_
42-8	7010-7013	the	_
42-9	7014-7019	whole	_
42-10	7020-7028	amygdala	_
42-11	7029-7030	,	_
42-12	7031-7033	as	_
42-13	7034-7038	well	_
42-14	7039-7041	as	_
42-15	7042-7045	the	_
42-16	7046-7050	left	_
42-17	7051-7054	and	_
42-18	7055-7060	right	_
42-19	7061-7069	amygdala	_
42-20	7070-7080	separately	_
42-21	7081-7082	,	_
42-22	7083-7090	because	_
42-23	7091-7093	of	_
42-24	7094-7103	potential	_
42-25	7104-7115	hemispheric	_
42-26	7116-7126	functional	_
42-27	7127-7138	differences	_
42-28	7139-7140	,	_
42-29	7141-7143	as	_
42-30	7144-7148	seed	_
42-31	7149-7156	regions	_
42-32	7157-7158	.	_

43-1	7159-7161	We	_
43-2	7162-7166	also	_
43-3	7167-7175	examined	_
43-4	7176-7180	each	_
43-5	7181-7183	of	_
43-6	7184-7187	the	_
43-7	7188-7192	four	_
43-8	7193-7201	amygdala	_
43-9	7202-7214	subdivisions	_
43-10	7215-7218	and	_
43-11	7219-7223	left	_
43-12	7224-7227	and	_
43-13	7228-7233	right	_
43-14	7234-7245	subdivision	_
43-15	7246-7248	in	_
43-16	7249-7259	additional	_
43-17	7260-7268	analyses	_
43-18	7269-7271	to	_
43-19	7272-7279	explore	_
43-20	7280-7285	which	_
43-21	7286-7297	subdivision	_
43-22	7298-7306	accounts	_
43-23	7307-7310	for	_
43-24	7311-7314	the	_
43-25	7315-7323	findings	_
43-26	7324-7332	observed	_
43-27	7333-7336	for	_
43-28	7337-7340	the	_
43-29	7341-7346	whole	_
43-30	7347-7355	amygdala	_
43-31	7356-7357	.	_

44-1	7358-7361	2.5	_
44-2	7362-7366	Seed	_
44-3	7367-7379	region-based	_
44-4	7380-7386	linear	_
44-5	7387-7398	correlation	_
44-6	7399-7402	and	_
44-7	7403-7409	random	_
44-8	7410-7417	effects	_
44-9	7418-7426	analysis	_
44-10	7427-7430	The	_
44-11	7431-7435	BOLD	_
44-12	7436-7440	time	_
44-13	7441-7448	courses	_
44-14	7449-7453	were	_
44-15	7454-7462	averaged	_
44-16	7463-7472	spatially	_
44-17	7473-7477	over	_
44-18	7478-7482	each	_
44-19	7483-7487	seed	_
44-20	7488-7494	region	_
44-21	7495-7496	.	_

45-1	7497-7500	For	_
45-2	7501-7511	individual	_
45-3	7512-7524	participants	_
45-4	7525-7526	,	_
45-5	7527-7529	we	_
45-6	7530-7538	computed	_
45-7	7539-7542	the	_
45-8	7543-7554	correlation	_
45-9	7555-7566	coefficient	_
45-10	7567-7574	between	_
45-11	7575-7578	the	_
45-12	7579-7587	averaged	_
45-13	7588-7592	time	_
45-14	7593-7599	course	_
45-15	7600-7602	of	_
45-16	7603-7607	each	_
45-17	7608-7612	seed	_
45-18	7613-7619	region	_
45-19	7620-7623	and	_
45-20	7624-7627	the	_
45-21	7628-7632	time	_
45-22	7633-7640	courses	_
45-23	7641-7643	of	_
45-24	7644-7647	all	_
45-25	7648-7653	other	_
45-26	7654-7659	brain	_
45-27	7660-7666	voxels	_
45-28	7667-7668	.	_

46-1	7669-7671	To	_
46-2	7672-7678	assess	_
46-3	7679-7682	and	_
46-4	7683-7690	compare	_
46-5	7691-7694	the	_
46-6	7695-7699	rsFC	_
46-7	7700-7701	,	_
46-8	7702-7704	we	_
46-9	7705-7714	converted	_
46-10	7715-7720	these	_
46-11	7721-7726	image	_
46-12	7727-7731	maps	_
46-13	7732-7733	,	_
46-14	7734-7739	which	_
46-15	7740-7744	were	_
46-16	7745-7748	not	_
46-17	7749-7757	normally	_
46-18	7758-7769	distributed	_
46-19	7770-7771	,	_
46-20	7772-7774	to	_
46-21	7775-7776	z	_
46-22	7777-7782	score	_
46-23	7783-7787	maps	_
46-24	7788-7790	by	_
46-25	7791-7797	Fisher	_
46-26	7798-7799	’	_
46-27	7800-7801	s	_
46-28	7802-7803	z	_
46-29	7804-7813	transform	_
46-30	7814-7815	:	_
46-31	7816-7817	.	_

47-1	7818-7820	In	_
47-2	7821-7824	the	_
47-3	7825-7831	second	_
47-4	7832-7837	level	_
47-5	7838-7846	analysis	_
47-6	7847-7848	,	_
47-7	7849-7851	we	_
47-8	7852-7862	correlated	_
47-9	7863-7866	the	_
47-10	7867-7868	Z	_
47-11	7869-7872	map	_
47-12	7873-7877	with	_
47-13	7878-7881	the	_
47-14	7882-7889	alcohol	_
47-15	7890-7899	substance	_
47-16	7900-7911	involvement	_
47-17	7912-7913	(	_
47-18	7914-7919	AlcSI	_
47-19	7920-7921	)	_
47-20	7922-7927	score	_
47-21	7928-7932	with	_
47-22	7933-7936	age	_
47-23	7937-7939	as	_
47-24	7940-7941	a	_
47-25	7942-7951	covariate	_
47-26	7952-7953	.	_

48-1	7954-7956	In	_
48-2	7957-7960	all	_
48-3	7961-7969	analyses	_
48-4	7970-7972	we	_
48-5	7973-7982	evaluated	_
48-6	7983-7986	the	_
48-7	7987-7994	results	_
48-8	7995-7997	at	_
48-9	7998-7999	a	_
48-10	8000-8009	voxelwise	_
48-11	8010-8019	threshold	_
48-12	8020-8022	of	_
48-13	8023-8024	p	_
48-14	8025-8026	<	_
48-15	8027-8032	0.001	_
48-16	8033-8038	whole	_
48-17	8039-8044	brain	_
48-18	8045-8056	uncorrected	_
48-19	8057-8059	in	_
48-20	8060-8071	combination	_
48-21	8072-8076	with	_
48-22	8077-8084	cluster	_
48-23	8085-8086	p	_
48-24	8087-8088	<	_
48-25	8089-8093	0.05	_
48-26	8094-8095	,	_
48-27	8096-8105	corrected	_
48-28	8106-8109	for	_
48-29	8110-8115	False	_
48-30	8116-8125	Discovery	_
48-31	8126-8130	Rate	_
48-32	8131-8132	(	_
48-33	8133-8136	FDR	_
48-34	8137-8138	)	_
48-35	8139-8140	,	_
48-36	8141-8150	following	_
48-37	8151-8158	current	_
48-38	8159-8168	reporting	_
48-39	8169-8178	standards	_
48-40	8179-8180	.	_

